)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
LAVA Therapeutics
LAVA Therapeutics (LVTX) investor relations material
LAVA Therapeutics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary9 Dec, 2025
Executive summary
Entered into a share purchase agreement with XOMA Royalty Corporation for acquisition via tender offer, including a cash payment and contingent value rights (CVRs) per share.
Amended agreement in October 2025 reduced minimum closing net cash condition and extended offer expiration.
Discontinued all clinical and nonclinical programs, including LAVA-1207 and LAVA-1266, as part of a strategic restructuring.
Workforce reduced by approximately 71% to 10 full-time employees by September 30, 2025.
Financial highlights
Cash and cash equivalents were $49.7 million as of September 30, 2025, up from $35.0 million at December 31, 2024.
Net loss for the nine months ended September 30, 2025 was $19.3 million, compared to $21.2 million for the same period in 2024.
No revenue recognized in 2025; $7.0 million revenue recognized in 2024 from a Pfizer milestone.
Operating loss for the nine months ended September 30, 2025 was $22.4 million, down from $22.8 million in 2024.
Gain on extinguishment of borrowings of $5.2 million recognized in 2025 due to loan forgiveness.
Outlook and guidance
Future operations highly dependent on successful completion of the XOMA Transaction.
If the transaction is not completed, strategic alternatives including dissolution and liquidation may be pursued.
Cash and cash equivalents expected to be sufficient to fund planned expenditures for at least the next twelve months.
Primary drivers for CVR payment realization?
What is the risk to meeting the $24.5M net cash condition?
Strategy for LAVA-1266 assets post-discontinuation?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from LAVA Therapeutics
- Board recommends approval of XOMA acquisition, offering cash, CVR, and merger reorganization.LVTX
Proxy Filing2 Dec 2025 - Acquisition for $1.16–$1.24 per share plus CVR, board support, EGM vote, and delisting planned.LVTXProxy Filing2 Dec 2025
- Board recommends shareholders approve sale for $1.04 plus CVR per share and post-offer merger.LVTXProxy Filing2 Dec 2025
- Board recommends approval of XOMA's $1.16–$1.24/share offer plus CVR and post-offer merger.LVTXProxy Filing2 Dec 2025
- AGM to vote on annual accounts, auditor, director reappointments, and share buyback authorization.LVTXProxy Filing2 Dec 2025
- AGM to vote on 2024 accounts, auditor, director reappointments, and share repurchase authority.LVTXProxy Filing2 Dec 2025
- AGM proposals include auditor changes, director reappointments, and share repurchase authorization.LVTXProxy Filing2 Dec 2025
- Tender offer for LAVA shares extended; shareholders to vote on acquisition before November 2025.LVTXProxy Filing2 Dec 2025
- Amended offer provides $1.04 per share plus CVR, with closing expected in Q4 2025.LVTXProxy Filing2 Dec 2025
- Shareholders to vote on acquisition offer involving cash and CVRs, pending key approvals.LVTXProxy Filing2 Dec 2025
Next LAVA Therapeutics earnings date
Q4 202524 Mar, 2026
LAVA Therapeutics
Next LAVA Therapeutics earnings date
Q4 202524 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage